Radioiodine therapy in benign thyroid diseases: effects, side effects, and factors affecting therapeutic outcome
SJ Bonnema, L Hegedüs - Endocrine reviews, 2012 - academic.oup.com
Radioiodine (131I) therapy of benign thyroid diseases was introduced 70 yr ago, and the
patients treated since then are probably numbered in the millions. Fifty to 90% of …
patients treated since then are probably numbered in the millions. Fifty to 90% of …
Radio-iodide treatment: from molecular aspects to the clinical view
A De la Vieja, G Riesco-Eizaguirre - Cancers, 2021 - mdpi.com
Simple Summary This year marks the 80th commemoration of the first time that radio-iodide
treatment (RAI) was used. RAI is one of the most effective targeted internal radiation …
treatment (RAI) was used. RAI is one of the most effective targeted internal radiation …
Thyroid stunning: fact or fiction?
IR McDougall, A Iagaru - Seminars in nuclear medicine, 2011 - Elsevier
Stunning of thyroid tissue by diagnostic activities of 131I has been described by some
investigators and refuted by others. The support both for and against stunning has at times …
investigators and refuted by others. The support both for and against stunning has at times …
Iodine mediated mechanisms and thyroid carcinoma
XH Liu, GG Chen, AC Vlantis… - Critical reviews in …, 2009 - Taylor & Francis
Iodine is a key element in the synthesis of thyroid hormones and the process of iodine
transport by thyroid cells is active. Iodine deficiency, which is a known risk factor for thyroid …
transport by thyroid cells is active. Iodine deficiency, which is a known risk factor for thyroid …
Mean and maximum standardized uptake values in [18F]FDG-PET for assessment of histopathological response in oesophageal squamous cell carcinoma or …
M Schmidt, E Bollschweiler, M Dietlein… - European journal of …, 2009 - Springer
Purpose To evaluate the potential of [18 F] fluorodeoxyglucose positron emission
tomography (FDG-PET) for the assessment of histopathological response and survival after …
tomography (FDG-PET) for the assessment of histopathological response and survival after …
No Adverse Affect in Clinical Outcome Using Low Preablation Diagnostic 131I Activity in Differentiated Thyroid Cancer: Refuting Thyroid-Stunning Effect
BK Yap, B Murby - The Journal of Clinical Endocrinology & …, 2014 - academic.oup.com
Context: Published studies of thyroid stunning due to preablation 131I scanning in the
treatment of differentiated thyroid cancer after thyroidectomy had shown inconsistent clinical …
treatment of differentiated thyroid cancer after thyroidectomy had shown inconsistent clinical …
Radioactive EGFR antibody cetuximab in multimodal cancer treatment: stability and synergistic effects with radiotherapy
D Rades, C Wolff, R Nadrowitz, C Breunig… - International Journal of …, 2009 - Elsevier
PURPOSE: Systemic therapies when added to whole brain radiotherapy have failed to
improve the survival of patients with multiple brain metastases. The epidermal growth factor …
improve the survival of patients with multiple brain metastases. The epidermal growth factor …
Thyroid stunning in radioiodine-131 therapy of benign thyroid diseases
C Happel, WT Kranert, H Ackermann, I Binse… - Endocrine, 2019 - Springer
Purpose Existence and cause of thyroid stunning was controversially discussed for decades
but the underlying mechanism remains unclear. Numerous studies describe thyroid stunning …
but the underlying mechanism remains unclear. Numerous studies describe thyroid stunning …
99mTcO4−-, Auger-Mediated Thyroid Stunning: Dosimetric Requirements and Associated Molecular Events
Low-energy Auger and conversion electrons deposit their energy in a very small volume (a
few nm3) around the site of emission. From a radiotoxicological point of view the effects of …
few nm3) around the site of emission. From a radiotoxicological point of view the effects of …
Implication of different clinical and pathological variables in patients with differentiated thyroid cancer on successful ablation for 3700 MBq 131I: a single Egyptian …
ME Husseini - Annals of nuclear medicine, 2016 - Springer
Objective Is to investigate possible factors predicting success of ablation for 3700 MBq
radioactive iodine 131 in patients with differentiated thyroid cancer (DTC) following near …
radioactive iodine 131 in patients with differentiated thyroid cancer (DTC) following near …